National Institute of Allergy and Infectious Diseases (NIAID)
N/A
2004-09-01
The purpose of this study is to measure the immune response (how the body fights infection)
to an experimental preparation of live Respiratory Syncytial Virus (RSV). A better
understanding of this virus may be useful in development of vaccines and treatments.
Participants will include 20 healthy adults age 21-40. Study procedures will include drawing
blood, urine samples, respiratory exams, vital signs and temperature, diary cards, nasal
mucus weight and nasal washes and swabs. All participants will receive vaccine via nose
drops. Patients will participate in the study for about 2 months.
Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children
Completed
Johns Hopkins Bloomberg School of Public Health
Phase 1
2009-11-01
Human parainfluenza viruses (HPIVs) are a major health concern in infants and young children
under 5 years of age, causing serious respiratory tract disease. The primary purpose of this
study is to test the safety of and immune response to a new HPIV vaccine in healthy infants
and children.
Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children
Completed
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1
2009-11-01
Human parainfluenza viruses (HPIVs) are a major health concern in infants and young children
under 5 years of age, causing serious respiratory tract disease. The primary purpose of this
study is to test the safety of and immune response to a new HPIV vaccine in healthy infants
and children.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
